Literature DB >> 6128285

Pharmacologic effect of somatostatin on bile formation in the dog. Enhanced ductular reabsorption as the major mechanism of anticholeresis.

E René, R G Danzinger, A F Hofmann, M Nakagaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6128285

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  12 in total

Review 1.  Physiology of cholangiocytes.

Authors:  James H Tabibian; Anatoliy I Masyuk; Tetyana V Masyuk; Steven P O'Hara; Nicholas F LaRusso
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 2.  Pathobiology of biliary epithelia.

Authors:  Angela C Cheung; Maria J Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-15       Impact factor: 5.187

3.  Somatostatin inhibits the effect of secretin on bile flow and on hepatic bilirubin transport in the rat.

Authors:  G L Ricci; J Fevery
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 4.  Endogenous somatostatin and the gut.

Authors:  M R Lucey
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

5.  Cholescintigraphic study of effect of somatostatin analog, octreotide, on bile secretion and gallbladder emptying in normal subjects.

Authors:  C Grimaldi; J Darcourt; A G Harris; E Lebot; F Lapalus; J Delmont
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

6.  Effect of somatostatin analog octreotide on human sphincter of Oddi.

Authors:  K F Binmoeller; R Dumas; A G Harris; J P Delmont
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

Review 7.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

8.  Hepatic bile formation in the rat. Addition of vasoactive intestinal peptide to the equation.

Authors:  R G Knodell; N M Steele; L N Stanley
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

9.  Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly.

Authors:  S M Catnach; J V Anderson; P D Fairclough; R C Trembath; P A Wilson; E Parker; G M Besser; J A Wass
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

10.  Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly.

Authors:  M F Stolk; K J van Erpecum; H P Koppeschaar; W I de Bruin; J B Jansen; C B Lamers; G P van Berge Henegouwen
Journal:  Gut       Date:  1993-06       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.